WHO ICTRP trial

Assessment of serological responses to Hepatitis B and Hib vaccines in infants…

ISRCTN28820504 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN28820504
Public title Assessment of serological responses to Hepatitis B and Hib vaccines in infants receiving vitamin A (Ghana)
Scientific title Assessment of serological responses to Hepatitis B and Hib vaccines in infants receiving vitamin A (Ghana)
Primary sponsor World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Specified
Countries Ghana;Switzerland
Conditions Immunology/vaccines Infections and Infestations Vaccination again disease
Interventions Treatment group: 1. Mothers at 6 weeks: 200,000 IU Vitamin A x 2 (day 1 and day 2) 2. Infants at 6, 10 and 14 weeks: 50,000 IU Vitamin A and Diphtheria, Pertussis, Tetanus (DPT), Hepatitis B (HepB) and Haemophilus influenzae type b (Hib)…
Registration date Sep 22, 2004
Target size 1042
Secondary IDs WHO/RPC041
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations